EUVIMEDObjevte EUVIMED
EUVIMED · CrossrefJournal

Journal of Clinical Oncology

ISSN 0732-183X · American Society of Clinical Oncology (ASCO)

Latest articles

  1. Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial

    Bruno Meduri, Antonella Baldissera, Cinzia Iotti, Luc J.E.E. Scheijmans, Marcel R. Stam, Salvatore Parisi, Liesbeth J. Boersma, Ilario Ammendolia, Eveline Koiter, Paola Canino, Dianne M. Busz, Marika Stenfert Kroese, Patrizia Giacobazzi, Maria P. Ruggieri, Antoine Engelen, Tindara Munafò, Karolien Verhoeven, Mariacarla Valli, Roberto Vicini, Riccardo Cuoghi Costantini, Elisa D'Angelo, Frank Lohr, Roberto D'Amico, Giovanni Frezza, Philip Poortmans, Selena Ciabatti, Filippo Bertoni, Elena Zanella, Gabriele Guidi, Stefano Scicolone, Shaniko Kaleci, Giovanni Tazzioli, Sabrina Cossa, Alessandra Iannelli, Pietro Corsa, Michele Troiano, El Jaouni Mohammad Khali, Giorgio Tolento, Alessio G. Morganti, Luciano Scandolaro

    Published: 2026-11-17DOI: 10.1200/jco-26-00969

  2. Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial

    Paul La Rosée, Philipp Ernst, Christian Fabisch, Annamaria Brioli, Dominik Wolf, Lino L. Teichmann, Ludwig Fischer von Weikersthal, Susanne Saussele, Theresa Früh, Frank Stegelmann, Cornelius F. Waller, Bernd Hertenstein, Tim H. Brümmendorf, Andreas Burchert, Jenny Rinke, Ali Albeer, Thomas Ernst, Markus Pfirrmann, Andreas Hochhaus

    Published: 2026-11-13DOI: 10.1200/jco-26-00899

  3. Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index

    Saurabh Zanwar, Doris K. Hansen, Oren Pasvolsky, Carlyn Tan, Lauren C. Peres, Utkarsh Goel, Rakesh Popat, Aimaz Afrough, Sireesha Asoori, Masooma Rana, Mrugakshi Dave, Andrew Portuguese, Efstathios Kastritis, James A. Davis, Joaquin Martinez-Lopez, Douglas Sborov, Jana Mihalyova, Susan Bal, Murali Janakiram, Darren Pan, Leyla Shune, Christopher Ferreri, Noa Biran, Megan Herr, Ariel Grajales-Cruz, Jack Khouri, Andre De Menezes Silva Corraes, Omar Castaneda Puglianini, Emily C. Liang, Eli Zolotov, Tiffany Richards, Mahmoud Gaballa, Gliceida Galarza Fortuna, Kelley Julian, Kimberly Green, Aishwarya Sannareddy, Larry D. Anderson, Shahzad Raza, Danai Dima, Lekha Mikkilineni

    Published: 2026-11-13DOI: 10.1200/jco-26-01039

  4. Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras

    Aislinn Macklin-Doherty, David Cunningham, Ian Chau, Andrew Bates, Kim Benstead, Mark Bower, Murray Brunt, Paul Fields, George Follows, Christopher P. Fox, John Frew, John G. Gribben, Peter Hoskin, Clive Irwin, Lisa Lowry, John Radford, Isabel Syndikus, Anjali Zarkar, Emma Thomas, Amy Berrington de Gonzalez, Michael E. Jones, Anthony J. Swerdlow

    Published: 2026-11-12DOI: 10.1200/jco-26-00418

  5. Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study

    Amanda L. Nash, Yan Li, Samantha M. Thomas, Akiko Chiba, Astrid Botty van den Bruele, Jennifer K. Plichta, Laura H. Rosenberger, Maggie DiNome, Susan McDuff, Amanda Francescatti, Anne McCarthy, Ronald Weigel, Thomas Lynch, Elizabeth S. Frank, Ann H. Partridge, Alastair M. Thompson, Terry Hyslop, Marc D. Ryser, E. Shelley Hwang

    Published: 2026-11-10DOI: 10.1200/jco-25-02476

  6. Dynamic Circulating Tumor DNA Methylation Monitoring Guiding Postoperative Surveillance in Nonmetastatic Colorectal Cancer: A Prospective, Randomized, Phase III FIND Trial

    Shaobo Mo, Chaoqiang Zhou, Maoguang Ma, Wenqin Luo, Yaqun Li, Ping Lu, Peiyuan Tang, Yaqi Li, Xiaoji Ma, Xiang Hu, Chunliang Cheng, Jiajun Yang, Changhua Zhuo, Jinliang Jian, Cheng Yu, Jinhuo Ding, Chaoxia Xiong, Fei Jiang, Rongrong Mu, Zhuo Lu, Jiayi Yu, Shengnan Jin, Ju Luan, Xinxiang Li, Sanjun Cai, Hai Zou, Yiwei Li, Qingguo Li, Fangqi Liu, Chunming Ding, Junjie Peng

    Published: 2026-11-10DOI: 10.1200/jco-25-03009

  7. Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial

    Yu Sunakawa, Manabu Shiozawa, Takanori Watanabe, Hirofumi Ota, Hisateru Yasui, Taichi Yabuno, Mitsuyoshi Tei, Mitsugu Kochi, Dai Manaka, Hisatsugu Ohori, Tatsuro Yamaguchi, Tamotsu Sagawa, Masahito Kotaka, Yutaro Kubota, Takashi Sekikawa, Masato Nakamura, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii, Akihito Tsuji

    Published: 2026-11-10DOI: 10.1200/jco-26-00355

  8. Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505)

    Matthew M. Poppe, Jennifer J. Le-Rademacher, Bruce G. Haffty, Eric K. Hansen, Jayant P. Agarwal, Jamie L. Wagner, Iwa Kong, Jane M. Armer, Doug W. Arthur, Timothy J. Whelan, Odum Kour, Minji K. Lee, Kathryn J. Ruddy, Ann H. Partridge, Lisa A. Carey, Maryam Lustberg, Michael B. Bernstein, Selina L. Chow, Shane R. Stecklein, David K. Gaffney, Atif J. Khan

    Published: 2026-11-10DOI: 10.1200/jco-26-00474

  9. RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial

    Rashmi Chugh, Arun Singh, Vladimir Andelkovic, Atrayee Basu Mallick, Bruce Brockstein, Nam Bui, Sant Chawla, Edwin Choy, Lara E. Davis, Mrinal Gounder, Shadi Haddadin, Bernd Kasper, Hyo Song Kim, Alexander Lee, Jeremy Lewin, Nadia Hindi, Prabhjot Mundi, Ravin Ratan, Winette van der Graaf, Janet Yoon, Matthew Birrenkott, Gerald Fetterly, Katie Newhall, Eric Song, Jonathan Yovell, Robin L. Jones, Vladimir Andelkovic, Bruce Brockstein, Nam Bui, Sant Chawla, Edwin Choy, Rashmi Chugh, Lara Davis, Mrinal Gounder, Shadi Haddadin, Nadia Hindi, Robin Jones, Bernd Kasper, Daniela Katz, Hyo Song Kim

    Published: 2026-11-10DOI: 10.1200/jco-26-00725

Volumes

2026 · 9,9502025 · 8,8002024 · 8,1722023 · 8,1202022 · 7,4742021 · 6,4682020 · 7,8602019 · 7,5262018 · 8,2022017 · 7,8552016 · 7,9002015 · 7,4922014 · 7,5792013 · 7,0662012 · 7,4562011 · 6,9222010 · 5,9392009 · 5,3762008 · 5,5462007 · 5,3152006 · 4,9992005 · 5,1232004 · 4,4202003 · 9192002 · 7872001 · 6302000 · 5781999 · 5321998 · 5681997 · 4811996 · 4431995 · 4331994 · 4111993 · 3691992 · 3091991 · 3281990 · 3051989 · 2901988 · 2741987 · 319

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.